NUVB

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Nuvation Bio Inc

NYSE | NUVB

4.84

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 24, 2025)

$1.66B

Market Cap

-

P/E Ratio

-0.38

EPS

$4.87

52 Week High

$1.54

52 Week Low

HEALTHCARE

Sector

NUVB Chart

Recent Chart
Price Action

NUVB Technicals

Tags:

NUVB Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $795K
Total Revenue $7.9M
Cost Of Revenue $7.1M
Costof Goods And Services Sold $7.1M
Operating Income -$593M
Selling General And Administrative $69M
Research And Development $99M
Operating Expenses $586M
Investment Income Net -
Net Interest Income $27M
Interest Income $27M
Interest Expense $341K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $683K
Income Before Tax -$568M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$568M
Comprehensive Income Net Of Tax -
Ebit -$568M
Ebitda -$567M
Net Income -$568M

Revenue & Profitability

Earnings Performance

NUVB Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $541M
Total Current Assets $526M
Cash And Cash Equivalents At Carrying Value $36M
Cash And Short Term Investments $36M
Inventory -
Current Net Receivables $16M
Total Non Current Assets $14M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $4.6M
Intangible Assets Excluding Goodwill $4.6M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $467M
Other Current Assets $7.3M
Other Non Current Assets -
Total Liabilities $77M
Total Current Liabilities $58M
Current Accounts Payable $6.3M
Deferred Revenue -
Current Debt -
Short Term Debt $7.9M
Total Non Current Liabilities $19M
Capital Lease Obligations $2.6M
Long Term Debt -
Current Long Term Debt $6.3M
Long Term Debt Noncurrent -
Short Long Term Debt Total $8.9M
Other Current Liabilities $35M
Other Non Current Liabilities -
Total Shareholder Equity $464M
Treasury Stock -
Retained Earnings -$911M
Common Stock $1.4B
Common Stock Shares Outstanding $269M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$130M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $683K
Capital Expenditures $162K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $123M
Cashflow From Financing $331K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$568M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $795K
Total Revenue $7.9M
Cost Of Revenue $7.1M
Costof Goods And Services Sold $7.1M
Operating Income -$593M
Selling General And Administrative $69M
Research And Development $99M
Operating Expenses $586M
Investment Income Net -
Net Interest Income $27M
Interest Income $27M
Interest Expense $341K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $683K
Income Before Tax -$568M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$568M
Comprehensive Income Net Of Tax -
Ebit -$568M
Ebitda -$567M
Net Income -$568M

NUVB News

NUVB Profile

Nuvation Bio Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Nuvation Bio Inc. is a clinical-stage biopharmaceutical company based in New York, focused on the development of innovative therapies for cancer treatment. The company is advancing a robust and diverse pipeline of drug candidates, addressing significant unmet medical needs in the oncology space. With an emphasis on precision medicine and the integration of novel therapeutic approaches, Nuvation Bio seeks to improve patient outcomes while positioning itself for substantial growth within the biopharmaceutical industry.

BYND
-23.06%
$2.18
WGRX
+185.43%
$1.14
VHAI
-50.00%
$0.00
TOVX
+0.87%
$0.34
YYAI
-14.98%
$0.07
VIVK
+11.91%
$0.29
F
+12.15%
$13.84
YDKG
-15.04%
$0.06
ASST
+27.28%
$1.10
INTC
+0.31%
$38.28
BURU
+17.26%
$0.40
CENN
-0.74%
$0.21
DVLT
+52.00%
$3.42
CGBS
-39.47%
$0.03
NVDA
+2.25%
$186.26
BITF
+10.68%
$4.61
TSLA
-3.39%
$433.72
AAL
+7.90%
$13.78
DNN
+2.93%
$2.81
CJET
+27.98%
$0.11
RGTI
-1.90%
$38.84
NEUP
+54.07%
$6.24
ADTX
-28.06%
$0.21
PLUG
+2.43%
$2.95
T
+2.11%
$25.14
RIG
+0.25%
$3.90
SCNX
-39.61%
$1.57
NOK
+2.10%
$6.30
AMD
+7.63%
$252.92
QBTS
+5.11%
$32.65
AXDX
-61.36%
$0.03
ABEV
-0.90%
$2.19
GPUS
+4.19%
$0.40
WTO
-7.14%
$0.06
RF
+1.95%
$24.57
CAN
+7.38%
$1.89
LAES
+22.55%
$7.01
SOFI
+3.31%
$29.01
NEHC
+48.35%
$5.86
NUAI
+48.35%
$5.86
QLGN
+3.11%
$3.64
ONDS
+5.66%
$7.46
GRAB
+2.27%
$5.85
TLRY
+0.67%
$1.49
QS
+14.73%
$16.82
ADAP
-7.57%
$0.06
SNAP
+1.01%
$7.95
CIFR
+19.73%
$20.66
AIRE
-22.42%
$0.76
ETHD
-3.52%
$3.83
JOBY
+2.93%
$16.13
ACHR
+3.48%
$11.29
IONZ
-4.02%
$3.82
RMBL
+60.50%
$3.21
RXRX
+5.41%
$6.04
BAC
+1.56%
$52.57
AMZN
+1.41%
$224.21
NIO
+0.14%
$6.90
AAPL
+1.24%
$262.82
ADD
-25.47%
$0.05
QUBT
-2.57%
$15.53
IREN
+12.60%
$62.90
BTBT
+5.10%
$3.91
RR
+12.17%
$6.08
AMC
-1.46%
$2.69
NVTS
+3.37%
$14.07
SRM
+53.27%
$10.30
PLTR
+2.29%
$184.63
CLOV
+19.37%
$3.82
UUUU
+0.51%
$21.37
BTG
-0.38%
$5.21
DFLI
+13.27%
$1.28
RVPH
+18.99%
$0.67
BBD
0.00%
$3.35
MARA
+1.66%
$19.54
KDLY
+5.66%
$0.84
NAKA
+5.66%
$0.84
APLD
+0.14%
$33.43
CUTR
-10.19%
$0.09
PBR
-0.84%
$11.74
WU
+10.19%
$8.97
GOOGL
+2.70%
$259.92
SOUN
-1.42%
$17.98
WLGS
-5.57%
$0.04
RIVN
-0.84%
$12.98
IONQ
+1.56%
$60.30
VZ
+1.09%
$38.82
PFE
+0.36%
$24.76
WULF
+6.44%
$13.71
LAZR
+31.36%
$2.22
ETWO
0.00%
$3.30
RGTZ
+3.08%
$15.36
SKYQ
+9.15%
$0.50
MU
+5.95%
$219.02
JBLU
0.00%
$4.57
SMCI
+0.77%
$48.29
CLSK
+9.59%
$19.36
WBD
-0.47%
$21.15
LUMN
+3.85%
$8.09
HOOD
+4.06%
$139.79
BYND
-23.06%
$2.18
WGRX
+185.43%
$1.14
VHAI
-50.00%
$0.00
TOVX
+0.87%
$0.34
YYAI
-14.98%
$0.07
VIVK
+11.91%
$0.29
F
+12.15%
$13.84
YDKG
-15.04%
$0.06
ASST
+27.28%
$1.10
INTC
+0.31%
$38.28
BURU
+17.26%
$0.40
CENN
-0.74%
$0.21
DVLT
+52.00%
$3.42
CGBS
-39.47%
$0.03
NVDA
+2.25%
$186.26
BITF
+10.68%
$4.61
TSLA
-3.39%
$433.72
AAL
+7.90%
$13.78
DNN
+2.93%
$2.81
CJET
+27.98%
$0.11
RGTI
-1.90%
$38.84
NEUP
+54.07%
$6.24
ADTX
-28.06%
$0.21
PLUG
+2.43%
$2.95
T
+2.11%
$25.14
RIG
+0.25%
$3.90
SCNX
-39.61%
$1.57
NOK
+2.10%
$6.30
AMD
+7.63%
$252.92
QBTS
+5.11%
$32.65
AXDX
-61.36%
$0.03
ABEV
-0.90%
$2.19
GPUS
+4.19%
$0.40
WTO
-7.14%
$0.06
RF
+1.95%
$24.57
CAN
+7.38%
$1.89
LAES
+22.55%
$7.01
SOFI
+3.31%
$29.01
NEHC
+48.35%
$5.86
NUAI
+48.35%
$5.86
QLGN
+3.11%
$3.64
ONDS
+5.66%
$7.46
GRAB
+2.27%
$5.85
TLRY
+0.67%
$1.49
QS
+14.73%
$16.82
ADAP
-7.57%
$0.06
SNAP
+1.01%
$7.95
CIFR
+19.73%
$20.66
AIRE
-22.42%
$0.76
ETHD
-3.52%
$3.83
JOBY
+2.93%
$16.13
ACHR
+3.48%
$11.29
IONZ
-4.02%
$3.82
RMBL
+60.50%
$3.21
RXRX
+5.41%
$6.04
BAC
+1.56%
$52.57
AMZN
+1.41%
$224.21
NIO
+0.14%
$6.90
AAPL
+1.24%
$262.82
ADD
-25.47%
$0.05
QUBT
-2.57%
$15.53
IREN
+12.60%
$62.90
BTBT
+5.10%
$3.91
RR
+12.17%
$6.08
AMC
-1.46%
$2.69
NVTS
+3.37%
$14.07
SRM
+53.27%
$10.30
PLTR
+2.29%
$184.63
CLOV
+19.37%
$3.82
UUUU
+0.51%
$21.37
BTG
-0.38%
$5.21
DFLI
+13.27%
$1.28
RVPH
+18.99%
$0.67
BBD
0.00%
$3.35
MARA
+1.66%
$19.54
KDLY
+5.66%
$0.84
NAKA
+5.66%
$0.84
APLD
+0.14%
$33.43
CUTR
-10.19%
$0.09
PBR
-0.84%
$11.74
WU
+10.19%
$8.97
GOOGL
+2.70%
$259.92
SOUN
-1.42%
$17.98
WLGS
-5.57%
$0.04
RIVN
-0.84%
$12.98
IONQ
+1.56%
$60.30
VZ
+1.09%
$38.82
PFE
+0.36%
$24.76
WULF
+6.44%
$13.71
LAZR
+31.36%
$2.22
ETWO
0.00%
$3.30
RGTZ
+3.08%
$15.36
SKYQ
+9.15%
$0.50
MU
+5.95%
$219.02
JBLU
0.00%
$4.57
SMCI
+0.77%
$48.29
CLSK
+9.59%
$19.36
WBD
-0.47%
$21.15
LUMN
+3.85%
$8.09
HOOD
+4.06%
$139.79
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.